| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |